Skip to main navigation Skip to search Skip to main content

Non-participation in systematic screening for osteoporosis-the ROSE trial

  • M J Rothmann
  • , S Möller
  • , T Holmberg
  • , M Højberg
  • , J Gram
  • , Mickael Bech
  • , K Brixen
  • , A P Hermann
  • , C-C Glüer
  • , R Barkmann
  • , K H Rubin
  • University of Southern Denmark
  • VIVE - Det Nationale Forsknings- og Analysecenter for Velfærd
  • Odense University Hospital
  • Christian-Albrechts-Universitäts
  • UCL University College

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Population-based screening for osteoporosis is still controversial and has not been implemented. Non-participation in systematic screening was evaluated in 34,229 women age 65–81 years. Although participation rate was high, non-participation was associated with comorbidity, aging other risk factors for fractures, and markers of low social status, e.g., low income, pension, and living alone. A range of strategies is needed to increase participation, including development of targeted information and further research to better understand the barriers and enablers in screening for osteoporosis.
Original languageEnglish
JournalOsteoporosis International
Volume28
Issue number12
Pages (from-to)3389–3399
Number of pages10
ISSN0937-941X
DOIs
Publication statusPublished - 5 Sept 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Non-participation in systematic screening for osteoporosis-the ROSE trial'. Together they form a unique fingerprint.

Cite this